Shockwaves delivery for aortic valve therapy-Realistic perspective for clinical translation?

calcific aortic valve disease decalcification lithotripsy medical device ultrasound

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2023
Historique:
received: 07 02 2023
accepted: 23 03 2023
medline: 28 4 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

Calcific aortic valve disease (CAVD) is the most frequent valvular heart disorder, and the one with the highest impact and burden in the elderly population. While the quality and standardization of the current aortic valve replacements has reached unprecedented levels with the commercialization of minimally-invasive implants and the design of procedures for valve repair, the need of supplementary therapies able to block or retard the course of the pathology before patients need the intervention is still awaited. In this contribution, we will discuss the emerging opportunity to set up devices to mechanically rupture the calcium deposits accumulating in the aortic valve and restore, at least in part, the pliability and the mechanical function of the calcified leaflets. Starting from the evidences gained by mechanical decalcification of coronary arteries in interventional cardiology procedures, a practice already in the clinical setting, we will discuss the advantages and the potential drawbacks of valve lithotripsy devices and their potential applicability in the clinical scenario.

Identifiants

pubmed: 37113704
doi: 10.3389/fcvm.2023.1160833
pmc: PMC10128859
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1160833

Informations de copyright

© 2023 Curini and Pesce.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Circ Cardiovasc Interv. 2019 Oct;12(10):e008434
pubmed: 31553205
Sci Rep. 2022 Nov 27;12(1):20400
pubmed: 36437309
Can J Cardiol. 2022 Oct;38(10):1474-1475
pubmed: 35644333
Cardiovasc Revasc Med. 2020 Oct;21(10):1262-1268
pubmed: 32147133
Kans Med. 1989 Jan;90(1):19-22
pubmed: 2709649
EuroIntervention. 2019 Oct 20;15(8):714-721
pubmed: 31062700
JAMA Cardiol. 2020 Oct 1;5(10):1170-1175
pubmed: 32639511
Eur Heart J Suppl. 2020 Nov 18;22(Suppl L):L49-L52
pubmed: 33654467
J Am Coll Cardiol. 2020 Dec 1;76(22):2635-2646
pubmed: 33069849
J Biomech. 2008 Aug 28;41(12):2612-7
pubmed: 18701107
J Cell Sci. 2015 May 15;128(10):1865-75
pubmed: 25918124
Nat Rev Dis Primers. 2016 Mar 03;2:16006
pubmed: 27188578
JACC Cardiovasc Interv. 2021 Jun 28;14(12):1352-1361
pubmed: 34167675
Int J Biochem Cell Biol. 2003 Feb;35(2):113-8
pubmed: 12479860
J Biomed Mater Res A. 2017 Oct;105(10):2729-2741
pubmed: 28589644
Eur Heart J. 2021 Jan 21;42(4):358
pubmed: 33160283
Semin Vasc Surg. 1998 Sep;11(3):142-8
pubmed: 9763114
J Mol Cell Cardiol. 2014 Feb;67:49-59
pubmed: 24368096
Cardiovasc Eng Technol. 2018 Jun;9(2):158-167
pubmed: 29761409
Exp Gerontol. 2020 Nov;141:111088
pubmed: 32911032
Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2910-2921
pubmed: 33086873
Am J Surg. 1993 Apr;165(4):431-4
pubmed: 8480876
Biomaterials. 2018 Oct;181:268-279
pubmed: 30096561
J Cardiovasc Med (Hagerstown). 2022 Jul 1;23(7):487-492
pubmed: 35763774
AsiaIntervention. 2021 Dec;7(2):116-117
pubmed: 34913017
Cardiovasc Revasc Med. 2011 Mar-Apr;12(2):129-30
pubmed: 21421192
Eur Heart J. 2020 Feb 21;41(8):933-939
pubmed: 31504400
Circulation. 2019 Feb 5;139(6):834-836
pubmed: 30715944
Medicina (Kaunas). 2021 Jul 14;57(7):
pubmed: 34356992
Eur Heart J. 2022 Feb 12;43(7):683-697
pubmed: 34849696
J Vis Exp. 2022 Mar 9;(181):
pubmed: 35343967
JACC Cardiovasc Interv. 2019 Mar 11;12(5):502-504
pubmed: 30846091
Expert Rev Cardiovasc Ther. 2022 Apr;20(4):323-338
pubmed: 35466834
Vascular. 2022 Nov 17;:17085381221140616
pubmed: 36394946
Cureus. 2020 Jul 22;12(7):e9335
pubmed: 32850209
Eur Heart J. 2018 Jul 21;39(28):2655
pubmed: 29420723
Theranostics. 2022 Mar 14;12(6):2758-2772
pubmed: 35401829
Am J Pathol. 2007 Nov;171(5):1407-18
pubmed: 17823281
J Urol. 1982 Mar;127(3):417-20
pubmed: 6977650
Biomedicines. 2022 Sep 21;10(10):
pubmed: 36289611
Heart Lung Circ. 2022 Nov;31(11):e135-e139
pubmed: 35985946
Front Pharmacol. 2020 May 13;11:685
pubmed: 32477143
Circulation. 2015 Jun 2;131(22):1989-2000
pubmed: 25832034
JACC Cardiovasc Interv. 2021 Jun 28;14(12):1275-1292
pubmed: 34167671
Diagn Interv Radiol. 2019 Sep;25(5):392-397
pubmed: 31358488
Eur Heart J. 2022 Jun 1;43(21):2081
pubmed: 35134879
Front Cardiovasc Med. 2016 Nov 04;3:44
pubmed: 27867942
Front Cardiovasc Med. 2022 Mar 25;9:850393
pubmed: 35402526
Circ Res. 2013 Jul 5;113(2):223-37
pubmed: 23833296
J Acoust Soc Am. 2005 Oct;118(4):2667-76
pubmed: 16266186
Nat Mater. 2013 Jun;12(6):576-83
pubmed: 23603848
JACC Cardiovasc Imaging. 2017 Aug;10(8):897-906
pubmed: 28797412
EuroIntervention. 2022 Sep 20;18(7):574-581
pubmed: 35318955
Interv Cardiol. 2019 Nov 18;14(3):154-163
pubmed: 31867062

Auteurs

Lavinia Curini (L)

Unità di Ricerca in Ingegneria Tissutale Cardiovascolare, Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Maurizio Pesce (M)

Unità di Ricerca in Ingegneria Tissutale Cardiovascolare, Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Classifications MeSH